Whole Blood and Red Cell ATP Content in Patients With Peripheral Vascular Disease: The Effect of Cigarette Smoking and Oxpentifylline

Angiology ◽  
1984 ◽  
Vol 35 (10) ◽  
pp. 628-632 ◽  
Author(s):  
Ronald J. Maughan ◽  
John Broom ◽  
George Smith ◽  
John B. Leiper ◽  
Antoine K. Ah-See ◽  
...  
The Lancet ◽  
1976 ◽  
Vol 307 (7961) ◽  
pp. 666-668 ◽  
Author(s):  
H.L Reid ◽  
J.A Dormandy ◽  
A.J Barnes ◽  
P.J Lock ◽  
T.L Dormandy

1992 ◽  
Vol 20 (1) ◽  
pp. 45-53 ◽  
Author(s):  
M Lunetta ◽  
T Salanitri

The aim of the double-blind, crossover, placebo-controlled study was to evaluate whether oral administration of sulodexide, a medium molecular weight glycosaminoglycan, had an effect on whole blood, plasma and serum viscosity, and/or plasma fibrinogen concentrations. The drug was administered orally at a dose of 500 lipoproteinlipase releasing units twice daily for 1 month to two groups of 20 patients with peripheral vascular disease; one group was administered a placebo–drug sequence and the other a drug–placebo sequence. Orally administered sulodexide had a marked effect on plasma viscosity and on plasma fibrinogen concentrations, whereas there were no effects on whole blood viscosity. No significant side-effects were observed. The fact that sulodexide was highly effective, even after oral administration, suggests it may be useful for the treatment of patients with atheromatous vascular diseases of the lower limbs requiring chronic therapy.


2019 ◽  
Vol 7 (7) ◽  
pp. 77
Author(s):  
Satılmış ◽  
Karabulut

A traditional hematological marker, red cell distribution width (RDW), is accepted as a novel marker of atherosclerotic vascular diseases. Clinical importance of the RDW as a prognostic biomarker in peripheral vascular disease (PVD) has been reported in a few studies. Herein, we aimed to show the correlation between RDW and PVD severity and its complexity in terms of angiographic evaluation. A total of 118 patients who underwent peripheral lower extremity angiography were subsequently evaluated retrospectively. Upon admission, RDW level was measured with automated complete blood count. Severity and complexity of the PVD was evaluated according to Trans-Atlantic Inter-Society Consensus (TASC II) classification. A TASC II A-B lesion was defined as simple PVD, and a TASC II C-D lesion was defined as prevalent and complex PVD. Then, both groups were compared statistically according to clinical, laboratory, and demographic features, including RDW levels. In 49.6% of the patients, TASC II C-D lesions were observed. Advanced age, male gender, and body mass index (BMI) were associated with TASC II groups. Red cell distribution width levels were correlated with presence of PVD, as well as TASC II grades (p:0.02). The fourth quartile (75th percentile) of the RDW levels was 14.1, and patients with RDW levels ≥14.1 had a more significant correlation with the presence and severity of PVD (p:0.001). In the multivariate regression analysis, elevated RDW was found to be an independent predictor of the presence of PVD and also TASC II C-D lesions (OR:2.26, with a 95% confidence interval (CI) 0.051–0.774; p:0.02). Elevated RDW levels was associated with TASC II C-D lesions, which indicated more prevalent and complex PVD.


1989 ◽  
Vol 79 (8) ◽  
pp. 398-402 ◽  
Author(s):  
LA Levy

Virtually no attention has been given in public education efforts to the potentially devastating effects of smoking on the lower extremities. An analysis of the epidemiologic studies that have been done by the Office of the Surgeon General and other clinical investigators has been presented, leading to the conclusion that cigarette smoking is the single most powerful risk factor for peripheral vascular disease. In the care of patients with peripheral vascular disease, the podiatric physician has an opportunity to be a participant in efforts to solve one of the nation's major public health problems.


Sign in / Sign up

Export Citation Format

Share Document